In an immunohistochemistry study on a series of resected NSCLC patients conducted by Mandarano et al (41), authors found a strong relationship in 34 (17.62%) of cases presenting a co-expression of both high IDO-1 and PD-L1 (p = 0.0003). Here, IDO1 is linked to non-small cell lung carcinoma.